The Ocular Coil is intended to provide drug delivery to the ocular surface. This study will evaluate the safety and tolerability of the placebo Ocular Coil in healthy subjects.

This study is designed to evaluate the safety and comfort of a placebo Ocular Coil for 28 days in 40 healthy subjects.

Inclusion Criteria:

• Age between 18 and 75 years old
• Informed and having given informed consent
• Willing and able to comply with scheduled visits and other study procedures

Exclusion Criteria:

• Subjects with a history of eye disease that can make them vulnerable for irritation by the coil.
• Subjects wearing contact lenses (unless they are willing to replace them for glasses for the duration of the study).
• Subjects using eye drops (during the study).
• Subjects with an Oriental/Asian lid crease, because of their narrow fornix.
• Subjects who do not speak and/or write Dutch properly.
• Subjects with a history of serious adverse reaction or hypersensitivity to components of the ocular coil. or to ophthalmic anaesthetics
• Women who are pregnant or nursing their child, or have the intention to become pregnant during the course of the study.